Medicinal Products

453. Deputy Ken O'Flynn asked the Minister for Health whether there are cancer drugs currently accessible to private patients in Ireland which are not reimbursed for public patients; and the steps being taken to eliminate this disparity in access. [52824/25]

208. Deputy Grace Boland asked the Minister for Health the current policy regarding the availability of weight loss medications, for persons on low incomes, including those with medical cards; the plans to expand access to these medications for persons who do not have diabetes but are struggling with obesity; and if she will make a statement on the matter. [52482/25]

209. Deputy Grace Boland asked the Minister for Health the steps being taken to ensure equitable access to clinically approved weight loss drugs for lower-income earners; and if she will make a statement on the matter. [52483/25]

210. Deputy Grace Boland asked the Minister for Health for an update on the HSE’s assessment of the inclusion of weight loss medications for non-diabetic patients on the reimbursement list for medical card holders; the timeframe for a decision on this matter; and if she will make a statement on the matter. [52484/25]

211. Deputy Grace Boland asked the Minister for Health whether her Department has considered the potential impact on health inequalities if weight loss drugs remain inaccessible to lower-income groups; the measures being explored to address this issue; and if she will make a statement on the matter. [52485/25]

853. Deputy Ruth Coppinger asked the Minister for Health if she will support the full subsidy of maintenance and reliever therapy inhalers for those with asthma; and if she will make a statement on the matter. [51313/25]

348. Deputy Ruth Coppinger asked the Minister for Health to consider approving the use of CAR T-cell therapy in Ireland for those over the age of 26; and if she will make a statement on the matter. [51002/25]

194. Deputy Ken O'Flynn asked the Minister for Health the reason a medication (details supplied), which is used in the treatment of severe allergies, is not currently covered under the medical card scheme or the drugs payment scheme; if there are plans to include this treatment under either scheme; and if she will make a statement on the matter. [50820/25]

246. Deputy Colm Burke asked the Minister for Enterprise, Tourism and Employment if he is concerned by delays within Ireland’s system of reimbursement of new medicines; his views on whether this is an competitiveness issue; if he will raise delays with the Minister for Health; and if he will make a statement on the matter. [49733/25]

621. Deputy Louise O'Reilly asked the Minister for Health if she is aware that patients being prescribed concerta for the treatment of symptoms associated with ADHD by doctors in the CAMHS service have to leave that service and the prescribing element of that service at aged 18; if she is further aware that there is no adult clinic for ADHD for persons living in North County Dublin; if she will ad…

1155. Deputy Pádraig Rice asked the Minister for Health if she will expedite approval and funding of a new drug (details supplied) to treat those living with Barakat Syndrome; and if she will make a statement on the matter. [47827/25]

1160. Deputy Ann Graves asked the Minister for Health if she has increased the availability of naloxone-trained individuals on its use and equipped gardaí with naloxone to carry on the beat. [47836/25]

1161. Deputy Michael Healy-Rae asked the Minister for Health if plans are in place to allow tapeworm infection patients to access essential medicines currently unavailable in Ireland (details supplied); and if she will make a statement on the matter. [47837/25]

1267. Deputy Aindrias Moynihan asked the Minister for Health the up-to-date position on a medication being made available through the drugs payment scheme (details supplied); and if she will make a statement on the matter. [48470/25]

1277. Deputy Seán Crowe asked the Minister for Health the reason that a medication (details supplied) for the treatment of diabetes insipidus has been removed from the long-term illness scheme; and her views on whether beneficiaries of the scheme should be informed of changes to approved medication rather than discovering this when renewing prescriptions. [48600/25]

1288. Deputy Séamus McGrath asked the Minister for Health the position in relation to the approval of a drug (details supplied) used to treat people affected by Duchene muscular dystrophy; and if she will make a statement on the matter. [48657/25]

1294. Deputy Colm Burke asked the Minister for Health if consideration would be given to placing the drug known as Mounjaro under the HSE reimbursable items list as a treatment for obesity; and if she will make a statement on the matter. [48667/25]

1323. Deputy Michael Fitzmaurice asked the Minister for Health when the drug givinostat will be available through the HSE; and if she will make a statement on the matter. [48901/25]

1370. Deputy John Brady asked the Minister for Health if the drug cemiplimab is available in Ireland; if it is covered under the medical card scheme; and if she will make a statement on the matter. [49145/25]

2065. Deputy Ruth Coppinger asked the Minister for Health the steps being taken to address the lack of supply of a medicine (details supplied); and if she will make a statement on the matter. [44571/25]

2071. Deputy Thomas Gould asked the Minister for Health whether there is any regulation of the price of medicines to ensure cheapest possible access. [44588/25]

2076. Deputy Shónagh Ní Raghallaigh asked the Minister for Health to reconsider remarks made in Dáil Éireann on 6 March 2025 regarding the free HRT scheme, specifically the assertion that medication dispensed under the scheme must be for the purpose of alleviating symptoms related to menopause, when no such condition is outlined in the legislation underpinning the scheme; and if she will correct t…

2077. Deputy Ruth Coppinger asked the Minister for Health to address concerns raised in relation to the free HRT programme (details supplied); and if she will make a statement on the matter. [44599/25]

2081. Deputy Martin Daly asked the Minister for Health in light of the recent introduction of the free hormone replacement therapy measure for women experiencing menopause, if she has considered extending similar financial support to men diagnosed with hypogonadism or male menopause who require testosterone replacement therapy such as testogel given that both conditions involve hormone deficiencie…

2095. Deputy Paul Murphy asked the Minister for Health if it is HSE policy to instruct pharmacists to deny menopause products to transgender people under the free HRT scheme. [44661/25]